Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannaRoyalty Corp C.CRZ

Healthcare Drug Manufacturers - Major Cannabis
Origin House is a growing cannabis product and brands company operating across key markets in the U.S. and Canada. The company delivers over 130 branded cannabis products to the licensed dispensaries. It provides distribution, manufacturing, cultivation and marketing services for its brand partners. The company operates through two operating segments, The Corporate segment derives income from non-operating investment and The California Operations segment engaged in cultivation, manufacturing, an


CSE:CRZ - Post by User

CannaRoyalty Corp > financial report
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by investalot23on May 29, 2018 8:25pm
116 Views
Post# 28096525

RE:RE:RE:RE:RE:financial report

RE:RE:RE:RE:RE:financial reportJust reviewing the conference call. Thats 50M US if only w e can replicate 2017 this company is steal at 270 Market cap

"Over the past five months, we have announced the acquisition of substantial revenue generating Canada’s operators including distributors Alta and River that generated US$31.9 million in revenue in 2017. Also Kaya produced US$8 million in revenue in 2017 including the revenue that was generated by the former manufacturer of Bhang edibles. FloraCal generated US$6.4 million in revenue in 2017 along with US$3.2 million in EBITDA."
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities